Cambridge Cognition Share Discussion Threads

[phowdo] 15/12/2014 09:28

More director buys around the bid on Friday.
There was also a 296k transaction at that price - perhaps Nigel Wray?
Must be clearing a seller at that price anyway.

[battlebus2] 15/12/2014 09:25

Cambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests, has been notified of the following transactions by Directors, which took place on 12 December 2014.

Nick Kerton, Chief Executive Officer, purchased 45,615 ordinary shares at a price of 62.19 pence each. Following this notification, Dr Kerton now has a total beneficial interest of 172,900 Ordinary Shares representing 1.02% of the issued share capital of the Company.

Nick Walters, Chief Financial Officer, purchased 27,369 ordinary shares at a price of 62.19 pence each. Following this notification, Mr Walters has a total beneficial interest of 119,369 Ordinary Shares representing 0.71% of the issued share capital of the Company.

Michael Lewis, Chairman, purchased 13,684 ordinary shares at a price of 62.19 pence each. Following this notification, Mr Lewis has a total beneficial interest of 27,969 Ordinary Shares representing 0.17% of the issued share capital of the Company.

Cambridge Cognition's capital consists of 16,930,556 Ordinary Shares with voting rights. The Company does not hold any Ordinary Shares in Treasury.

[battlebus2] 30/10/2014 08:04

Morning janeann. Doing my best thanks.

[janeann] 30/10/2014 07:49

Morning Battlebus. Very positive recognition of Cogs technology. Trust all well.

[battlebus2] 30/10/2014 07:20

Supporting the Dementias Research Platform UK

Cambridge Cognition, (AIM: COG), which specialises in computerised neuropsychological tests, announces that the Company strongly supports the launch of The Medical Research Council ('MRC') Dementias Research Platform UK ('DPUK'). Cambridge Cognition's Cantab Connect is playing a significant role in the ongoing DPUK Dementia Deep and Frequent Phenotyping feasibility study.

This joint-funded National Institute for Health Research ('NIHR') and MRC project for intensive phenotyping of 24 pre-clinical Alzheimer's disease patients, aims to identify biomarkers that change over periods of months, rather than years. The Deep and Frequent Phenotyping study assesses key cognitive domains affected in Alzheimer's disease using Cambridge Cognition's rapid touchscreen cognitive test system, Cantab Connect.

Alongside the cognitive tests, the study uses an extensive range of MR imaging, additional clinical testing and biomarkers, at frequent intervals during the three months study period for each participant. The goal is to identify protocols and biomarkers that will be used in a wide range of follow-on trials

The MRC DPUK is a £53m public-private partnership with World leading researchers from Universities across the UK (Cambridge, Cardiff, Edinburgh, Imperial College, Oxford, Manchester, Newcastle, Swansea and UCL) and six companies (GlaxoSmithKline, Janssen Research & Development, AstraZeneca-MedImmune, Ixico, SomaLogic and Araclon) who will use state of the art technologies such as Cantab Connect to accelerate progress in dementias research. It brings together two million participants aged 50 and over, from 22 existing study groups within the UK, making it the World's largest population study for use in dementias research. The DPUK's aims are early detection, improved treatment and ultimately, prevention, of dementias.

Dr Jenny Barnett, Director of Healthcare Innovation at Cambridge Cognition commented: "We fully support the DPUK initiative and are pleased to see the UK setting a leading example to accelerate early detection of dementia and develop knowledge leading to new diagnostic procedures, drug treatments and other therapies that could prevent or delay the onset and progression of Alzheimer's and other neurodegenerative diseases."

Chief Executive Officer of Cambridge Cognition, Nick Kerton, commented: "This represents the largest population-based study on the progress of dementia. It is a testament to the quality and utility of the products that we have developed that they will be used as an integral part of this study."

[cheshire man] 03/10/2014 14:59

Indeed bb :-)

[battlebus2] 03/10/2014 10:32

Playful that made me chuckle :)))

You know me too well!!
Great to see us get it right again C.M.
And yes still holding.

[loobrush] 03/10/2014 09:30

Not many shares available so one needs to get in quick as could really motor as 20% holder NIgel Wray, renowned investor, will have plans to make this a big company.

[playful] 03/10/2014 08:57

He will be itching to comment as I’m certain this will not be a share he sold.

[cheshire man] 03/10/2014 08:25

Another lift this morning I see,,,,,,,wonder where battlebus is ?

[cheshire man] 02/10/2014 14:56

Also in today's #Shares: Finger on the Pulse, we discuss how IT is transforming the NHS and healthcare...

[cheshire man] 02/10/2014 14:52

Aaaaah Thanks LB :-)

[loobrush] 02/10/2014 14:43

Tipped in Shares mag today AS A BUY.

[cheshire man] 02/10/2014 13:03

No idea,just logged in now and very pleased whatever the reason is :-)

[paulypilot] 02/10/2014 11:25

Is anyone aware of a reason for this morning's rise? I wonder if it's been tipped in a magazine? My copies haven't arrived yet.

Nice little stock. Good contract wins & recent shrewd buying (Nigel Wray, and Directors).

Regards, Paul.

[phowdo] 02/10/2014 10:38

Options seem generous but good to see the director interests aligned with shareholders and that they've put their own money in too.
The large amounts of stock available in the past seems to have mostly been sold as well.
A few trades going through the ISDX.

[playful] 01/10/2014 17:45

Not much blue for me today so nice to see COG swim against the tide.

[loobrush] 01/10/2014 14:49

directors options granted , exercisable in tranches once share price exceeeds 90 p 120p and 200p.
This looks good to me as this gives them some really good targets to achieve.
200p would be really nice, just about 3 times today's price

[cheshire man] 01/10/2014 08:51

1/10/14 Cambridge Cognition Holdings PLC Director/PDMR Shareholding

[phowdo] 29/9/2014 10:50

Added a few more myself.

[battlebus2] 29/9/2014 10:49

More director buying including the CFO again...

[battlebus2] 26/9/2014 10:20

Moving on up :))

[battlebus2] 24/9/2014 16:48

My cognitive responses are aligned to new highs for the share price :))

[cheshire man] 24/9/2014 11:44

A huge vote of confidence :-)